• "Re-evaluation of variants of uncertain significance in patients with hereditary arrhythmogenic disorders"
• A Case of Anomalous Right Coronary Artery With Catastrophic Presentation
• A case of Williams syndrome with Wolff-Parkinson-White syndrome
• A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome
• A Comprehensive Review on Alcohol Abuse Disorder Fatality, from Alcohol Binges to Alcoholic Cardiomyopathy
• A narrative review of inherited arrhythmogenic syndromes in young population: role of genetic diagnosis in exercise recommendations
• Ablation of the epicardial substrate in patients with long-QT syndrome at risk of sudden death
• Acute Coronary Syndrome in an Anomalous Left Main Coronary Artery
• Advances and Challenges in the Management of Brugada Syndrome: A Comprehensive Review
• An unusual cause of inappropriate shocks delivered by an implantable cardioverter defibrillator
• Applying Artificial Intelligence for Phenotyping of Inherited Arrhythmia Syndromes
• Arrhythmic Mitral Valve Prolapse Syndrome and Ventricular Arrhythmias: A Comprehensive Review and the Role of Catheter Ablation
• Atypical Antipsychotics and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis
• Beneficial normalization of cardiac repolarization by carnitine in transgenic SQT1 rabbit models
• Brugada Syndrome and Pulmonary Atresia with Intact Interventricular Septum: Fortuitous Finding or New Genetic Connection?
• Brugada Syndrome in a Transplanted Heart: Implications for Organ Transplant Screening Process
• Brugada syndrome: identification of subjects at risk and therapy
• Can Hyperthermia Unveil Brugada Pattern?
• Cardiac channelopathies in the context of hereditary arrhythmia syndromes
• Cardiovascular abnormalities in patients with SHANK3 pathogenic variants: Beyond neurodevelopmental disorders and epilepsy
• Case report: arrhythmic mitral valve prolapse syndrome-are risk factors underdiagnosed?
• Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy
• Catheter ablation as an adjunctive therapy to ICD implantation in Brugada syndrome
• Catheter Ablation for Channelopathies: When Is Less More?
• Characterization of a novel SCN5A mutation associated with long QT syndrome and arrhythmogenic right ventricular cardiomyopathy in a family
• Clinical differences between drug-induced type 1 Brugada pattern and syndrome
• Clinical presentation and genetic characterization of early-onset atrial fibrillation in patients affected by long QT syndrome: A single-center experience
• Clinical Utility of Protein Language Models in Resolution of Variants of Uncertain Significance in <em>KCNQ1, KCNH2</em>, and <em>SCN5A</em> Compared With Patch-Clamp Functional Characterization
• Coenzyme Q deficiency may predispose to sudden unexplained death via an increased risk of cardiac arrhythmia
• Congenial short QT syndrome: A review focused on electrocardiographic features
• Congenital LMNA-Related Muscular Dystrophy in Paediatrics: Cardiac Management in Monozygotic Twins
• Congenital short QT syndrome: A review focused on electrocardiographic features
• Correlations of ventricular fibrillation and monomorphic ventricular tachycardia with SCN5A mutations and other clinical variables in Brugada syndrome
• Detection of a novel pathogenic variant in KCNH2 associated with long QT syndrome 2 using whole exome sequencing
• Determinants/Predictors of QT Abnormalities in Patients on Psychotropic Medications in a Nigerian Tertiary Hospital
• Diagnosis of Brugada syndrome affects quality of life and psychological status
• Digital precision medicine in rhythmology : Risk prediction of recurrences, sudden cardiac death, and outcome
• Distinct Electrogram Features and Ventricular Arrhythmia Induction Modes Between Repolarization and Conduction Heterogeneities
• Dynamic protein-protein interactions of KCNQ1 and KCNE1 measured by EPR line shape analysis
• Early, rapidly progressive vasculopathy in a transplanted heart: A possible complication of COVID-19
• Electrocardiographic abnormalities are frequently detected in healthy adult Borzoi with a normal echocardiogram
• Electrocardiographic Findings in Children Treated with Leuprolide Acetate for Precocious Puberty: Does it Cause Prolonged QT?
• Electrophysiological patterns and structural substrates of Brugada syndrome: Critical appraisal and computational analyses
• Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model
• Emotional awareness is correlated with ambulatory heart rate variability: A replication and extension
• Exploring the impact of a KCNH2 missense variant on Long QT syndrome: insights into a novel gender-selective, incomplete penetrance inheritance mode
• From rare events to systematic data collection: the RESCUED registry for sudden cardiac death in the young in Germany
• Genetic and clinical characteristics of catecholaminergic polymorphic ventricular tachycardia in a Taiwanese nationwide cohort
• Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients
• Genetic testing for Inherited Arrhythmia Syndromes and Cardiomyopathies: results of the European Heart Rhythm Association Survey
• Genetic testing in early-onset atrial fibrillation
• Human Genetics of Cardiac Arrhythmias
• Identification of a SCN5A Genetic Variant Associated With Type 1 Brugada Syndrome (BrS) in a Family
• Implantable Cardioverter-Defibrillator Placement in Spontaneous Coronary Artery Dissection: A Case Report
• Implantable loop recorder uncovered torsades de pointes in long-QT syndrome type 1 with multi cause of syncope
• Increased Heart Rate Fragmentation in Those with Williams-Beuren Syndrome Suggests Non-autonomic Mechanistic Contributors to Sudden Death Risk
• Increased heart rate fragmentation in those with Williams-Beuren syndrome suggests nonautonomic mechanistic contributors to sudden death risk
• Investigation of a Large Kindred Reveals Cardiac Calsequestrin (CASQ2) as a Cause of Brugada Syndrome
• Ion Channel Diseases as a Cause of Sudden Cardiac Death in Young People: Aspects of Their Diagnosis, Treatment, and Pathogenesis
• Late Gadolinium Enhancement in Early Repolarization Syndrome
• Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation
• Long-term follow-up of patients with Brugada syndrome: Foremost risk factors associated with overall arrhythmic events
• Molecular Autopsy With Banked Cord Blood Reveals Brugada Syndrome in Past Sudden Death Case
• Multicenter appraisal of comorbid TANGO2 deficiency disorder in patients with 22q11.2 deletion syndrome
• Multiple Anomalous Coronary Arteries With Right Sinus of Valsalva Origin: A Case Report
• Myocardial Bridging in Patients Undergoing Coronary Angiography for Coronary Artery Disease
• Neurocardiac pathologies associated with potassium channelopathies
• New Guidelines of Pediatric Cardiac Implantable Electronic Devices: What Is Changing in Clinical Practice?
• New Insights on Cardiac Arrhythmias in Patients With Kidney Disease
• No beneficial use of the wearable cardioverter defibrillator among patients suffering from inherited and congenital heart disease: data from a European multicenter registry
• Novel Gain-of-Function Mutation in the Kv11.1 Channel Found in the Patient with Brugada Syndrome and Mild QTc Shortening
• Opioids-Induced Long QT Syndrome: A Challenge to Cardiac Health
• Pediatric and Familial Genetic Arrhythmia Syndromes: SCN5A-Related Disorders When It Is Not Long QT Type 3: Clinical Signs and Symptoms
• Predicting and Recognizing Drug-Induced Type I Brugada Pattern Using ECG-Based Deep Learning
• Predicting ventricular arrhythmia inducibility in ajmaline-induced Brugada type I pattern: Validation of the dST-Tiso interval
• Predictors of Premature Ventricular Contractions Development in Patients With SARS-CoV-2 Infection
• Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis
• PRKAG2 syndrome, a rare hypertrophic cardiomyopathy: a Brazilian long-term follow-up with extracardiac disorders
• Proarrhythmic drugs, drug levels, and polypharmacy in victims of sudden arrhythmic death syndrome: An autopsy-based study from Denmark
• QT Prolongation Preceding Ventricular Fibrillation After Amiodarone Administration: A Case Report
• Rare Variant in MRC2 Associated With Familial Supraventricular Tachycardia and Wolff-Parkinson-White Syndrome
• Reevaluation of data interpretation in study on pre-excitation risk assessment
• Refractory coronary vasospasm complicated by complete atrio-ventricular block during neck surgery: is there an indication for pacing?
• Relationship Between Brugada Syndrome and Ischemic Stroke: A Case Report and Comprehensive Literature Review
• Risk scores in congenital long QT syndrome: friend or foe?
• S-ICD Implantation "Tips and Tricks"
• Single Construct Suppression and Replacement Gene Therapy for the Treatment of All CALM1-, CALM2-, and CALM3-Mediated Arrhythmia Disorders
• Spontaneous coronary artery dissection: a difficult journey from emergency coronary artery bypass grafting to left ventricular assist device
• Sudden cardiac arrest occurring in temporal proximity to consumption of energy drinks
• Targeting the I_Ks Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
• Temperature and ST-segment morphology remote monitoring: new perspectives for implantable cardiac monitors in Brugada syndrome
• The electromechanical window for arrhythmia-risk assessment
• The role of GPD1L, a sodium channel interacting gene, in the pathogenesis of Brugada Syndrome
• Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients
• Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial
• Utilizing median and maximum QTc values improves prediction of breakthrough cardiac events in pediatric long QT syndrome
• Ventricular arrhythmias during acute coronary syndrome: A gateway to sudden cardiac death?
• Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study
• Vigorous Exercise in Patients With Congenital Long-QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study
• What an anesthesiologist should know about pediatric arrhythmias